Lab Automation For In-vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
The Lab Automation Market for the In-vitro Diagnostics Market is expected to register a CAGR of 6.3% during the forecast period. The rise in testing as a result of the pandemic can be attributed to the growth in in-vitro diagnostic adoption. The growth of the market is anticipated to be fueled by the creation of automated in-vitro diagnostic systems for labs to provide quick, precise, and error-free diagnoses.
Key HighlightsThe lab automation for in-vitro diagnostics market is a consolidated market. The entry cost for setting up lab infrastructure remains high, and hence, there are only a few major players that dominate the market. Moreover, this market has undergone a round of consolidation already. The major players in this market are Cognex Corporation, Roche Holding AG, Thermo Fisher Scientific Inc., and Abbott Laboratories, among others. Market domination through innovative product launches and strategic agreements continues across this industry.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook